DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment

A new international study co-led by Johns Hopkins researchers shows that measuring circulating tumor DNA (ctDNA) can help personalize treatment for patients with Stage 3 colon cancer.

LEARN MORE

SEE ALL NEWS

Recent Posts

How a Division I athlete who never smoked turned his stage 4 ALK+ lung cancer diagnosis into a fight for a cure Solving a 15-Year Mystery: Scientists Discover How Gut Bacteria Toxin Invades Colon Cells to Trigger Cancer Advances in Treating Women’s Bladder Cancer Elena’s Story: Recurrent Brain Cancer After a year of turmoil, cancer researchers see promising signs for mRNA vaccines AI and Mammograms Single Nutrient Fuels Cancer-Fighting Power of T Cells Alcohol and Cancer Risk Colon Cancer Screening: What You Need to Know